Biphasic insulin aspart given thrice daily is as efficacious as a basal-bolus insulin regimen with four daily injections: a randomised open-label parallel group four months comparison in patients with type 2 diabetes.

Ligthelm, R J; Mouritzen, U; Lynggaard, H; Landin-Olsson, M; Fox, C; le Devehat, C; Romero, E; Liebl, A

Ligthelm, R J; Mouritzen, U; Lynggaard, H; Landin-Olsson, M; Fox, C; le Devehat, C; Romero, E; Liebl, A.

Affiliation

Ligthelm RJ; Havenziekenhuis, Rotterdam, The Netherlands. rjligthelm@cistron.nl

Exp Clin Endocrinol Diabetes ; 114(9): 511-9, 2006 Oct.

Article in En | MEDLINE | ID: mdl-17115349

Subject(s)

Diabetes Mellitus, Type 2/drug therapy; Insulin/analogs & derivatives; Aged; Biphasic Insulins; Blood Glucose/analysis; Body Weight/drug effects; Dose-Response Relationship, Drug; Drug Administration Routes; Drug Administration Schedule; Female; Humans; Hypoglycemia/drug therapy; Hypoglycemic Agents/administration & dosage; Injections; Insulin/administration & dosage; Insulin/adverse effects; Insulin Aspart; Insulin, Isophane; Male; Middle Aged; Treatment Outcome

Search on Google

XML

PubMed Links

Database: MEDLINE Main subject: Diabetes Mellitus, Type 2 / Insulin Type of study: Clinical_trials / Guideline Limits: Aged / Female / Humans / Male / Middle aged Language: En Year: 2006 Type: Article

Search on Google

XML

PubMed Links